Such tumours do not metabolize glucose well – precluding their visualization via standard FDG-PET scans – but overexpress somatostatin receptors that bind, for example, to the PET agent 68 Ga-Dotatate ...

Background: Somatostatin analogue functional imaging with Ga-68 Dotatate PET/CT has demonstrated superiority in lesion detection in patients with NETs. The effect of this novel imaging modality on US ...

“Utilization of Gallium-68 Dotatate PET CT for the Evaluation of Head and Neck Paraganliomas in a Major Tertiary Academic University Neurosurgical Center,” Patrick Wojtylak, Sarah Ash, Robert ...

Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors (NETs): A sequential case series. This is an ASCO Meeting Abstract from the ...

The quantity and purity of germanium-68 is of great importance in producing gallium-68. In this study, the researchers from IMP reported an efficient method to produce and separate germanium-68.

ARTMS Inc. Submits Drug Master File for the First Ever Multi-Curie Production of Gallium-68 with ARTMS’ Solid Target Solution on Medical Cyclotrons March 31, 2021 08:00 AM Eastern Daylight Time ...

Advanced Accelerator Applications, of Saint-Genis-Pouilly, France, said it received FDA and EMA orphan drug designation status for its radiopharmaceutical, Gallium-68 DOTATATE for use as a diagnostic ...

To this end, the IAEA has published the TECDOC-1863 ‘Gallium-68 Cyclotron Production’ in February 2019. Recent response to this TECDOC and inquiries demonstrate that due to the complex technology ...

SPRINGFIELD, N.J., Dec. 12, 2022 /PRNewswire/ -- Evergreen Theragnostics has submitted a New Drug Application (NDA) for EVG-001 (Kit for preparation of Gallium-68 DOTATOC Injection), a ...

ARTMS/Odense University Hospital to Present Solid Target Gallium-68 Production Record at European Association of Nuclear Medicine October 10, 2019 08:00 AM Eastern Daylight Time ...

The eluted Ga-68, in the form of [68 Ga]GaCl 3, can be used for labelling and therefore has led to significant advances in Ga-68 chemistry and to the development of targeted PET radiopharmaceuticals.